Skip to main content
. 2019 Jan 3;34(1):361–374. doi: 10.1080/14756366.2018.1553167

Figure 15.

Figure 15.

Structure and biochemical characterisation of the allosteric inhibitors directed to the PIF-pocket of PDK1. EC50 (T308tide): compound concentration is required for 50% of maximum effect. EC50 (PDKtide): compound concentration is required to result in 50% displacement of the PDKtide from the PIF-pocket or ATP site in an AlphaScreen interaction-displacement assay.